Warning: This post is likely of no direct interest to most readers of this Blog – it is written for education and interest only, and outlines one of the potential advantages of using Options for portfolio insurance. These are nervous times and we should be concerned about preserving our hard-earned wealth in the months ahead. […]
Copernicus Portfolio Review: 11 March 2026
Copernicus is the equity portfolio scheduled for review this morning. Based on an over priced U.S. stock market I shifted the emphasis slightly, moving from the S&P 500 (VOO) over to several dividend oriented ETFs. Below you see a significant percentage of the portfolio focusing on VIG, SCHD and VYM. Yes, there will be overlapping […]
Bethe Portfolio Review: 10 March 2026
Bethe is the conservative asset allocation portfolio scheduled for review today. As I look over the current holdings, I may make a change in the future. One that merits change is to sell QUAL and replace it with SCHD. This switch would increase income and lower the overall portfolio beta. While the war in […]
Darwin 2026 Portfolio Review: 6 March 2026
It was a tough week for US Equiies with significant weakness on Tuesday and continuation to the end of the week that resuted in the SPX (S&P 500 Index) closing ~2% lower than last week’s close:
Kepler Portfolio Review: 6 March 2006
Before moving into the Kepler update, I set limit orders for VCR in all three Sector BPI portfolios (Carson, Franklin, & McClintock) as the Consumer sector dropped within a whisker of the 30% oversold bullish mark. Now for the Kepler update. As one of the poorer performing portfolios, the asset allocation was altered to be […]
Gauss Portfolio Review: 5 March 2026
Gauss is the portfolio up for review today. The owner of this portfolio is not contributing significant amounts of cash each month so the re-balancing will need to come from dividends and interest income. Gauss is a very conservative portfolio as one can see from the low beta value of 0.27. Conservative is defined in […]
Pauling Portfolio Review: 3 March 2026
Pauling is an asset allocation portfolio that is slowly working out of a performance deficit. Over the past few months I have been reworking the asset allocation mix and that work is not quite complete as readers will see in one of the following screenshots. Several asset classes are out of balance or not close […]
Huygens Portfolio Update: 2 March 2026
We begin the month of March with an update of the Huygens. The asset allocation model is a combination of equities for growth and income ETFs to provide some resistance should we see a major market draw-down. Below I will explain how I am using Trailing Stop Loss Orders (TSLOs) to reduce major losses.
Dirac 2026 Portfolio Review: 27 February, 2026
The objective of the Dirac Portfolio is to outperform the S&P 500 stocks, as represented by the SPY ETF, by rotating between sectors that make up the S&P 500 Index. Current analysis of the component sectors looks like this: with Buy or Hold recommendations for all but XLC (Communications), XLF (Financials), XLK (Technology) and XLY […]
Darwin 2026 Portfolio Review: 27 February 2026
It was another relatively uneventful week in the US Equity markets with the SPX (S&P 500 Index) remaining in the 6800-7000 consolidation range that it has now been in for ~3 months but with Fridays’s weakness resulting in a ~0.4% drop from last week’s close:
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 146
- Next Page »
You must be logged in to post a comment.